Why it was included in the FDA ban The FDA cites risk for immunogenicity, peptide-related impurities, and limited safety-related information as reasons for the BPC-157 ban
Buffer and Support Strategies Support sensitive skin during GHK-CU use with strategic product layering
Infection is rare but possible if the skin or equipment is not clean, which is one of the strongest arguments for having the injection done properly
BPC-157 is a synthetic peptide commonly discussed in wellness and regenerative medicine settings
Additionally, monitoring symptoms related to vitamin B12 deficiency, such as fatigue, weakness, and neurological changes, can help assess the overall effectiveness of treatment and guide further management strategies
To gain expertise in injection protocols , dosing adjustments, and evidence-based patient guidance, explore our aesthetic courses for medical professionals